Methods for treating visceral fat conditions Grant US-11324741-B2 United States of America 10 May 2022
Methods of providing weight loss therapy in patients with major depression Grant US-10322121-B2 United States of America 18 Jun 2019
Sustained-release formulations of topiramate Grant US-10314790-B2 United States of America 11 Jun 2019
Compositions and methods for weight loss in at risk patient populations Grant US-10231964-B2 United States of America 19 Mar 2019
Compositions and methods for reducing major adverse cardiovascular events Grant US-10231962-B2 United States of America 19 Mar 2019
Compositions and methods for weight loss in at risk patient populations Grant US-9801875-B2 United States of America 31 Oct 2017
Topiramate compositions and methods of enhancing its bioavailability Application US-9744137-B2 United States of America 29 Aug 2017
Sustained-release formulations of topiramate Grant US-9622983-B2 United States of America 18 Apr 2017
Sustained-release formulations of topiramate Application US-9555004-B2 United States of America 31 Jan 2017
Sustained-release formulations of topiramate Application US-9549940-B2 United States of America 24 Jan 2017
Compositions and methods for increasing insulin sensitivity Grant US-9457005-B2 United States of America 04 Oct 2016
Methods of providing weight loss therapy in patients with major depression Grant US-9248123-B2 United States of America 02 Feb 2016
Methods for administering weight loss medications Grant US-9125868-B2 United States of America 08 Sep 2015
Compositions and methods for weight loss in at risk patient populations Grant US-9119850-B2 United States of America 01 Sep 2015
Sustained-release formulations of topiramate Application US-8992989-B2 United States of America 31 Mar 2015
Sustained-release formulations of topiramate Application US-8889191-B2 United States of America 18 Nov 2014
Sustained-release formulations of topiramate Application US-8877248-B1 United States of America 04 Nov 2014
Sustained-release formulations of topiramate Application US-8663683-B2 United States of America 04 Mar 2014
Sustained-release formulations of topiramate Application US-8298576-B2 United States of America 30 Oct 2012
Sustained-release formulations of topiramate Application US-8298580-B2 United States of America 30 Oct 2012